Autor: |
David E Cantonwine, Thomas F McElrath, Michele R Hacker, Paige L Williams, Blair J Wylie, Russ Hauser, Andrea Bellavia, Karen O'Brien, Emma V Preston, Marlee R Quinn, Ellen W Seely, Florence M Brown, Camille E Powe, Zifan Wang, Kathryn S Tomsho, Tamarra James-Todd |
Jazyk: |
angličtina |
Rok vydání: |
2024 |
Předmět: |
|
Zdroj: |
BMJ Open, Vol 14, Iss 5 (2024) |
Druh dokumentu: |
article |
ISSN: |
2044-6055 |
DOI: |
10.1136/bmjopen-2023-079782 |
Popis: |
Purpose Pregnancy and the postpartum period are increasingly recognised as sensitive windows for cardiometabolic disease risk. Growing evidence suggests environmental exposures, including endocrine-disrupting chemicals (EDCs), are associated with an increased risk of pregnancy complications that are associated with long-term cardiometabolic risk. However, the impact of perinatal EDC exposure on subsequent cardiometabolic risk post-pregnancy is less understood. The Environmental Reproductive and Glucose Outcomes (ERGO) Study was established to investigate the associations of environmental exposures during the perinatal period with post-pregnancy parental cardiometabolic health.Participants Pregnant individuals aged ≥18 years without pre-existing diabetes were recruited at |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|